Patent Assignment
Reel/Frame 034723/0869
Assignment of Assignor's Interest
Recorded: 2015-01-15
Pages: 9
Assignors
CANYON PHARMACEUTICALS GROUP AG
Executed: 2015-01-12
CANYON PHARMACEUTICALS, INC.
Executed: 2015-01-12
CANYON PHARMACEUTICALS AG
Executed: 2015-01-12
Assignee
MARATHON PHARMACEUTICALS, LLC
1033 SKOKIE BOULEVARD, SUITE 600, NORTHBROOK, ILLINOIS, 60062
Covered Property
(1)
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Related Assignments
(13)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (First Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Agreement (Second Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Assignment of Assignor's Interest
May 7, 2025
From: MARATHON PHARMACEUTICALS, LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 071053/0651 →
Change of Name
May 7, 2025
From: VALEANT PHARMACEUTICALS INTERNATIONAL INC.
To: BAUSCH HEALTH COMPANIES INC.
Reel/Frame 071053/0649 →
U.S. Patent Security Agreement
Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0272 →
Canadian Intellectual Property Security Agreement
Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; 1261229 B.C. LTD.; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071566/0056 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →
Release of Security Interest
Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
Reel/Frame 073637/0126 →